In a case-control analysis, use of thiazolidinediones or metformin was associated with a lower risk of developing psoriasis.

Source: Inpharma, Volume 1, Number 1637, 2008-05-10 , pp. 16-16(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Acarbose, therapeutic use; Metformin, therapeutic use; Psoriasis, prevention; Sulfonylureas, therapeutic use; Thiazolidinediones, therapeutic use

Document Type: Research article

The full text article is available for purchase

$34.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A